Haloperidol and Lithium Blocking of the Mood Response to Intravenous Methylphenidate

Overview

Journal Psychopharmacology (Berl)

Specialty Pharmacology

Date 1978 Apr 14

PMID 96473

Citations 8

Authors

D Wald

R P Ebstein

R H Belmaker

Affiliations

Soon will be listed here.

Abstract

The euthymic manic-d-pressive patients with therapeutic plasma lithium levels were each given two i.f. infusions of 30 mg of methylphenidate. The infusions were separated by at least 3 days. Before one infusion each patient was given 5 mg of haloperidol i.v. and before the other infusion each was given an identical volume of saline. A psychiatric observer was blind to the nature of the pretreatment and the order of pretreatment was randomized. Saline pretreated patients showed marked activation and euphoriant responses despite therapeutic lithium levels. Haloperidol pretreatment reduced this response in three patients and eliminated the euphoriant and activating response in the remaining seven patients. These results agree with the existence of a dopaminergic step in the induction of methylphenidate-induced activation and euphoria.

Citing Articles

c-di-GMP modulates type IV MSHA pilus retraction and surface attachment in Vibrio cholerae.

Floyd K, Lee C, Xian W, Nametalla M, Valentine A, Crair B Nat Commun. 2020; 11(1):1549.

PMID: 32214098 PMC: 7096442. DOI: 10.1038/s41467-020-15331-8.

[New insights into the pathogenesis and pathophysiology of depression].

Schule C, Baghai T, Rupprecht R Nervenarzt. 2007; 78 Suppl 3:531-47.

PMID: 17960353 DOI: 10.1007/s00115-007-2370-5.

Pharmacokinetic and pharmacodynamic drug interactions in the treatment of attention-deficit hyperactivity disorder.

Markowitz J, Patrick K Clin Pharmacokinet. 2001; 40(10):753-72.

PMID: 11707061 DOI: 10.2165/00003088-200140100-00004.

Effects of lithium carbonate on methylphenidate-induced mood, behavior, and cognitive processes.

Huey L, Janowsky D, Judd L, ABRAMS A, Parker D, Clopton P Psychopharmacology (Berl). 1981; 73(2):161-4.

PMID: 6785807 DOI: 10.1007/BF00429209.

Lithium attenuates the activation-euphoria but not the psychosis induced by d-amphetamine in schizophrenia.

VAN KAMMEN D, Docherty J, Marder S, Rosenblatt J, Bunney Jr W Psychopharmacology (Berl). 1985; 87(1):111-5.

PMID: 3933028 DOI: 10.1007/BF00431789.

References

Jasinski D, Nutt J, HAERTZEN C, Griffith J, Bunney W . Lithium: effects on subjective functioning and morphine-induced euphoria. Science. 1977; 195(4278):582-4. DOI: 10.1126/science.319532. View

Schildkraut J . The catecholamine hypothesis of affective disorders: a review of supporting evidence. Am J Psychiatry. 1965; 122(5):509-22. DOI: 10.1176/ajp.122.5.509. View

Davies C, Sanger D, Steinberg H, Tomkiewicz M, UPrichard D . Lithium and alpha-methyl-p-tyrosine prevent "manic" activity in rodents. Psychopharmacologia. 1974; 36(3):263-74. DOI: 10.1007/BF00421808. View

Pijnenburg A, Honig W, van Rossum J . Inhibition of d-amphetamine-induced locomotor activity by injection of haloperidol into the nucleus accumbens of the rat. Psychopharmacologia. 1975; 41(2):87-95. DOI: 10.1007/BF00421062. View

TECCE J, Cole J . Amphetamine effects in man: paradoxical drowsiness and lowered electrical brain acitivity (CNV). Science. 1974; 185(4149):451-3. DOI: 10.1126/science.185.4149.451. View

Kadouch R, Belmaker R, Ebstein R, Peres L . Thphenidate. Neuropsychobiology. 1977; 3(4):250-5. DOI: 10.1159/000117610. View

Belmaker R, Ebstein R, SCHOENFELD H, Rimon R . The effect of haloperidol on epinephrine-stimulated adenylate cyclase in humans. Psychopharmacology (Berl). 1976; 49(2):215-7. DOI: 10.1007/BF00427293. View

VAN KAMMEN D, Murphy D . Attenuation of the euphoriant and activating effects of d- and l-amphetamine by lithium carbonate treatment. Psychopharmacologia. 1975; 44(3):215-24. DOI: 10.1007/BF00428897. View

Scheel-Kruger J . Some aspects of the mechanism of action of various stimulant amphetamine analogues. Psychiatr Neurol Neurochir. 1972; 75(3):179-92. View

10.

Jonsson L, ANGGARD E, Gunne L . Blockade of intravenous amphetamine euphoria in man. Clin Pharmacol Ther. 1971; 12(6):889-96. DOI: 10.1002/cpt1971126889. View

11.

Snyder S, Banerjee S, Yamamura H, Greenberg D . Drugs, neurotransmitters, and schizophrenia. Science. 1974; 184(4143):1243-53. DOI: 10.1126/science.184.4143.1243. View

12.

Angrist B, Sathananthan G, Wilk S, Gershon S . Amphetamine psychosis: behavioral and biochemical aspects. J Psychiatr Res. 1974; 11:13-23. DOI: 10.1016/0022-3956(74)90064-8. View

13.

Post R . Cocaine psychoses: a continuum model. Am J Psychiatry. 1975; 132(3):225-31. DOI: 10.1176/ajp.132.3.225. View

14.

Martin W, SLOAN J, SAPIRA J, Jasinski D . Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man. Clin Pharmacol Ther. 1971; 12(2):245-58. DOI: 10.1002/cpt1971122part1245. View

15.

Thornburg J, Moore K . The relative importance of dopaminergic and noradrenergic neuronal systems for the stimulation of locomotor activity induced by amphetamine and other drugs. Neuropharmacology. 1973; 12(9):853-66. DOI: 10.1016/0028-3908(73)90038-5. View

16.

Gerner R, Post R, Bunney Jr W . A dopaminergic mechanism in mania. Am J Psychiatry. 1976; 133(10):1177-80. DOI: 10.1176/ajp.133.10.1177. View

17.

Oppenheim G, Ebstein R, Belmaker R . Effect of lithium on the physostigmine-induced behavioral syndrome and plasma cyclic GMP. J Psychiatr Res. 1979; 15(2):133-8. DOI: 10.1016/0022-3956(79)90024-4. View

18.

Furukawa T, Ushizima I, Ono N . Modifications by lithium of behavioral responses to methamphetamine and tetrabenazine. Psychopharmacologia. 1975; 42(3):243-8. DOI: 10.1007/BF00421263. View

19.

Belmaker R, Wald D . Haloperidol in normals. Br J Psychiatry. 1977; 131:222-3. DOI: 10.1192/bjp.131.2.222b. View

20.

ANDEN N, Butcher S, CORRODI H, Fuxe K, Ungerstedt U . Receptor activity and turnover of dopamine and noradrenaline after neuroleptics. Eur J Pharmacol. 1970; 11(3):303-14. DOI: 10.1016/0014-2999(70)90006-3. View